We establish a novel method for the induction and collection of mesenchymal stem cells using a typical cell surface marker, CD105, through adipogenesis from mouse ES cells. ES cells were cultured in a medium for adipogenesis. Mesenchymal stem cells from mouse ES cells were easily identified by the expression of CD105, and were isolated and differentiated into multiple mesenchymal cell types. Mesenchymal stem cells showed remarkable telomerase activity and sustained their growth for a long time with a high potential for differentiation involving skeletal myogenesis in vitro. When mesenchymal stem cells were transplanted into the injured tibialis anterior muscles, they differentiated into skeletal muscle cells in vivo. In addition, they improved the vascular formation, but never formed teratoma for longer than 6 months. Gene expression profiles revealed that mesenchymal stem cells lost pluripotency, while they acquired high potential to differentiate into mesenchymal cell lines. They thus indicate a promising new source of cell-based therapy without teratoma formation.
Introduction
Mesenchymal stem cells (MSCs) have the potential to differentiate into any mesenchymal cell type such as osteocytes, chondrocytes, adipocytes and muscular cells. It is well known that MSCs can be isolated from several adult tissues including bone marrow and adipose tissues (Izadpanah et al., 2006; Fraser et al., 2006; Kern et al., 2006; Schffler and Büchler, 2007; Satija et al., 2007) . Those isolated from bone marrow are termed bone marrow-derived stem cells (BMSCs), and show a high potential for differentiation into mesenchymal cells and also neuro-differentiation capacity as well (Dezawa et al., 2005) . BMSCs, however, are quite limited in population and their invasive isolation involves risks. Adipose tissues have proved to be a useful and rich source of adipose tissue-derived mesenchymal stem cells (ADSCs). Although ADSCs have shown therapeutic efficiency in repairing damaged mesenchymal tissues, their isolation and purification from adult adipose tissue still involve complicated and troublesome procedures. Furthermore, they readily differentiate into adipocytes, osteocytes and chondrocytes but do not easily differentiate into skeletal muscular cells (Dicker et al., 2005; Izadpanah et al., 2006; Kern et al., 2006; Bunnell et al., 2008) .
Mouse embryonic stem cells (M-ESCs), on the other hand, are pluripotent, and their induction into adipocytes has been well described (Dani et al., 1997; Kawaguchi, 2006) . We initially supposed that a part of MSCs, like ADSCs, would appear through the process of differentiation into mesenchymal cell lines, such as adipogenesis from undifferentiated M-ESCs. The aim of this study was to establish a method for the induction and collection of MSCs through adipogenesis from M-ESCs without genetic manipulation. During the adipogenesis of M-ESCs, MSCs appeared to possess high potential for differentiation into mesenchymal cell lines including skeletal muscles both in vitro, and in vivo, but did not exhibit pluripotency. We further confirmed that these MSCs showed a high telomerase activity lacking in MSCs from adult tissue including BMCs and ADSCs. This advantage brought sustained growth with high potential for differentiation into any mesenchymal cell type in vitro. We also established that isolated MSCs possess different properties from undifferentiated M-ESCs. Rather than pluripotency, MSCs have displayed lineage-specific differentiation into cells of mesenchymal origin.
MSCs from M-ESCs were easily identified by the expression of CD105, which enabled us to obtain them in abundance. Our study results suggest that M-ESCs became a new source of MSCs, with their high differentiation potential confirmed in vitro and in vivo. They also enhanced vascular formation in recipient tissues after transplantation without the risk of teratoma formation. 
Materials and methods

M-ESCs
Mouse ES cells (G4-2; carrying the enhanced green fluorescent protein -EGFP -gene under the control of cytomegalovirus/ chicken b-actin promoter) were expanded in culture medium termed ES-DMEM. That is Dulbecco's modified Eagle's medium (Sigma; St. Louis, MO; www.sigma-aldrich.com) with 0.1 mM non-essential amino acids (GIBCO; Carlsbad, CA; www.invitro gen.com), 100 mM sodium pyruvate (GIBCO), 100 mM 2-mercaptoethanol (Sigma), 0.5% antibiotic-antimycotic (GIBCO) containing 10% fetal bovine serum (FBS; Biological Industries, Kibbuiz, Israel; www.bioind.com). For expansion of M-ESCs, 1000 U/mL of leukemia inhibitory factor (LIF; Chemicon, Temecula, CA; www.milli pore.com) was added in ES-DMEM.
Animals
Immunodeficient mice (SCID), 8-week-old, were purchased from Japan Charles River (Yokohama, Japan; www.crj.co.jp) and used under the guidelines for the Animal Care and Use of Nagoya University Graduate School of Medicine.
Generation, sorting and passage of MSCs
For the induction of adipogenesis, M-ESCs were incubated for 2 days without LIF and compacted to form embryoid bodies (EBs) in hanging drops. On the following 2 days, they were exposed to 10 À 7 M all-trans retinoic acid (RA; Sigma) in culture medium followed by washing for 2 days without RA. The EBs were plated onto gelatin-coated dishes and then incubated with 1.7 mM insulin (Sigma) and 0.3 mM 3,3,5-triiodo-L-thyronine (Sigma) in ES-DMEM after day 6 (Fig. 1) . Developing EBs were detached from the dishes, isolated with 5 mM EDTA in phosphate buffer saline (pH 7.4) and then sorted by a Magnetic Cell Separation System (MACS; Miltenyi Biotec, Auburn, CA; www.miltenyibiotec.com) using both an anti-CD105 antibody (R&D Systems, Minneapolis MN; www.RnDSystems.com) and an anti-rat antibody conjugated with magnetic beads (Miltenyi Biotec). Sample preparation, magnetic labeling and magnetic separation with mini-MS columns were conducted according to the manufacturer's instructions. Some samples were labeled with anti-CD105 antibody conjugated with phycoerythrin (PE) (R&D systems) and then incubated with anti-PE Micro Beads. Samples were processed for magnetic separation using mini-MS columns and analyzed by a Flow Cytometer, FACS Calibur (BD Biosciences, Franklin Lakes, NJ; www.bd.com). After MACS separation, cells non-specifically adhering to the MACS columns by the highly viscous force were removed using a short-time (4 h) culture in non-coating dishes. Floating cells were then transferred to coating dishes for culture as MSCs. MSCs were expanded using medium STK2 (DS Pharma Biomedical; Osaka, Japan; www.ds-pharma.co.jp). When passage was carried out every other day, MSCs were counted and examined for their differentiation potential by induction to mesenchymal cell lineages per below.
Isolation and culture of ADSCs from adipose tissues
ADSCs were isolated from adipose tissues surrounding testes. The protocol mainly followed that of an earlier report (Lin et al., 2006) . Fat tissues were dissected and minced in PBS containing 10% penicillin and streptomycin (Wako Chemicals; Osaka, Japan; www.wako-chem.co.jp). They were then incubated with an enzyme solution containing 1 mg/mL type I collagenase (Wako), 1% BSA (Sigma) and 10% penicillin and streptomycin (Wako) in PBS for 60 min at 37 1C. After stopping the enzyme reaction by cold PBS, cells released from adipose tissues were filtered through a cell strainer with 100 mm meshes (Falcon) and collected by centrifugation at 300g for 10 min. The pellet was resuspended in STK1 (DS Pharma Biomedical), a medium for a primary culture of mesenchymal stem cells, and cells were seeded on the plastic tissue culture dish (Falcon). After 24 h, floating cells were removed and attached cells were maintained in STK2 as ADSCs.
Fluorescent immunostaining
Cells and tissues were fixed with 4% paraformaldehyde for either 15 min or 3 h. Cryosections of tissues and cells adhering to dishes were processed for fluorescent immunostaining. Samples were incubated with the first antibodies followed by Alexa-labeled secondary antibodies. Either anti-CD105 rat monoclonal antibody (1:100; R&D), anti-myosin heavy chain mouse monoclonal antibody (1:200 
Karyotyping
MSCs after 10 passages were incubated in media containing 0.2 mg/mL corcemid (Chemicon, Temecula, CA; www.millipore. com) for 6 h at 37 1C, 5% CO 2 , trypsinized from the dish, resuspended in 0.075 mol/L KCl and incubated for 20 min at 37 1C, then fixed in 3:1 methanol acetic acid, and dropped on the slide glass, which was dried at room temperature, dyed with Giemsa liquid (Sigma) for 10-20 min, and observed under a microscope.
Quantitative telomerase activity assay
Telomerase activities of MSCs after MACS, undifferentiated ES cells, ADSCs from adipose tissues and mouse blood cells which were sucked from a heart (500 mL of blood) and subsequently separated by a centrifuge (1000 rpm 5 min) were measured using quantitative telomerase detection kit, which is categorized in telomeric repeat amplification protocol (TRAP; Allied Biotech, Inc., Vallejo, CA; www.alliedbiotechinc.com). The same number of cells (1 Â 10 5 cells) were lysed and processed for telomerase reaction followed by real-time PCR according to the manufacturer's instructions. Real-time PCR (35 cycles) was carried out by a real-time cycler Mx3000P (Stratagene, La Jolla, CA, www. stratagene.com). Quantitative results were analyzed using standard curve by template TSR Threshold cycle (C T ).
Induction to mesenchymal cell lineages
After sorting by MACS, both MSCs (CD105þ cells) and nonMSCs (CD105À cells) were differentiated into mesenchymal cells, respectively. For adipogenesis, they were allowed to continue to incubate in ES-DMEM containing 1.7 mM insulin (Sigma) and 0.3 mM 3,3,5-triiodo-L-thyronine (T3; Sigma). For osteogenesis, the cells were cultured with 0.1 mM dexamethasone (Sigma), 10 mM b-glycerol phosphate (Kanto Kagaku; Tokyo, Japan; www.kanto.co.jp), and 200 mM ascorbic acid (Sigma) in ES-DMEM.
For induction to skeletal muscle, cells after MACS were cultured in the ES-DMEM with 5% Knockout Serum Replacement (KSR Invitrogen) instead of 10% FBS. For induction to chondrocytes, cells were centrifuged in 5-mL tubes and cultured with ES-DMEM containing 10 ng/mL TGFb3 (Sigma) 100 nM PTH (Sigma), and 5% FBS in those same tubes. After induction for 2 weeks, the differentiation potential of CD105þ cells was measured. Adipogenic differentiation (n¼5) was demonstrated by the accumulation of neutral lipid vacuoles using Oil Red O. Osteogenic differentiation (n¼5) was confirmed by the deposition of mineralized matrix stained by Alizarin Red. Chondrogenic differentiation (n¼5) was confirmed by the formation of a sphere and the secretion of cartilage-specific proteoglycans stained with Alcian blue. Ten fields (395,411 mm 2 each) were chosen at random in each sample, and the ratio of positive area was calculated by a software BZ-II Analyzer (Keyence Co.; Osaka, Japan; www.key ence.co.jp). Myogenic differentiation (n¼5) was demonstrated by expression of MHC immunoreactivity, and calculated by the proportion of MHC-positive cell numbers per total cell numbers stained with DAPI. ADSCs from adipose tissues were also processed as mentioned above. 
Results
Appearance and sorting of MSCs
After 10 days of induction to adipogenesis, small, round CD105þ cells appeared at day 10, began to increase and reached their maximum population on day 14. Adipocytes then increased and CD105þ cells alternately decreased. Since double staining with CD105 and BODIPY demonstrated that adipocytes did not express CD105. Continuous observation of CD105þ cells from day 14 to day 21 by live staining with CD105 revealed that CD105þ cells became adipose cells increasing oil droplets in their cytoplasm (data not shown). Therefore, sorting by MACS was usually carried out on day 14 (Fig. 1A) . With continuous culture without adipogenesis after day 6, quite a few CD105þ cells appeared (Fig. 1B) . Since CD105þ cells demonstrated other markers of mesenchymal stem cells such as Thy-1, PDGFr-a, and Sca-1, we denoted CD105þ cells as MSCs (Fig. 1C) . The efficiency of sorting by MACS was confirmed by FACS analysis, and more than 91% of CD105þ MSCs cells were collected after MACS. The adhesion separation of non-specific cells after MACS further increased the purity of MSCs. Sorted MSCs were uniformly bipolar in shape, similar to that of the MSCs previously reported ( Fig. 2A, B) . MSCs had continued to increase the cell population and the cell number was counted at each passage every other day. They grew sequentially during more than 12 passages, and the population gradually reached the plateau level. During their growth, MSCs had sustained the expression of CD105 and the ratio of the positive cells was more than 96% (Fig. 2C, D) . On the other hand, ADSCs isolated from adipose tissue expressed CD105 like MSCs soon after the isolation (Supplement Fig. 1) . They increased the cell population until 5 passages, reached a plateau, and then attenuated after 7 passages (Fig. 2C) .
High potential for differentiation into mesenchymal cells
MSCs showed a high potential for differentiation into mesenchymal cells such as adipocytes, osteogenic cells, chondrocytes and skeletal muscle cells (Fig. 3A-D) . Both MSCs (CD105þ cells) and non-MSCs (CD105À cells) separated by MACS were differentiated into mesenchymal cells and compared with each other. After induction of adipogenesis, more than 97% of MSCs differentiated into adipocytes. Non-MSCs, however, did not produce large Oil Red O-positive oil droplets. MSCs turned Alizarin Red-positive after induction of osteogenesis. Non-MSCs did not survive under the condition of osteogenesis and disappeared. Under the pellet culture for chondrogenesis, MSCs formed small ball-like aggregations. When a cryo-section of the aggregations was stained with Alcian blue, the matrix surrounding the chondrocytes turned blue. The matrix produced by MSCs expressed collagen type II immunoreactivity, while non-MSCs did not form cell aggregations and were not stained with either Alcian blue or anti-collagen type II antibody. When MSCs differentiated into skeletal muscle cells, they became thin and fibrous, and began to express M-cadherin. They ran in the same direction and distributed parallel to each other. After 3 weeks of induction, they began to fuse together to form myotubes that expressed myosin heavy chain (MHC) immunoreactivity. DAPI staining revealed the formation of multinuclear cells. They finally constructed sarcomeres exhibiting bands with myosin and actin filaments regularly arrayed. A few non-MSCs expressed M-cadherin immunoreactivity, but did not form myotubes under the same condition (Fig. 3A-D) . Their potential for differentiation into mesenchymal cells was confirmed by the expression of their specific mRNAs detected by RT-PCR as well. After the induction of adipocytes and the formation of lipid droplets, MSCs expressed PPAR-g and LPL mRNAs. Following the formation of osteogenic cells, they displayed both Runx-2 and Osterix mRNAs. The small ball-like structures observed after the induction of chondrogenesis expressed Collagen2 and agglycan mRNAs. Skeletal muscle cells differentiating from MSCs expressed Myogenin, M-cadherin, MyoD and Myf5 mRNAs (Fig. 3Aii-Dii) .
The high potential for differentiation into mesenchymal cells was sustained for a long time until 10 passages. More than 90.0% of MSCs were able to differentiate into mesenchymal cells. The respective differentiation efficacies were approximately 97.76% of adipocytes, 94.9% of chondrocytes, and 93.0% of osteocytes (Fig. 4A) . After induction into skeletal muscle cells, about 33.61% of cells expressed MHC immunoreactivity. However, ADSCs isolated from adipose tissue showed extremely low differentiation potential at passage 5 while they increased the population sequentially. The respective differentiation efficacies were approximately 18.06% of adipocytes, 8.0% of osteocytes and 1.23% of skeletal muscle cells (Fig. 4A ). Our MSCs, in addition, grown by 10 passages, showed normal diploid karyotype when analyzed by a G-staining method (Fig. 4B) .
Higher activity of telomerase
Undifferentiated M-ESCs and MSCs showed high telomerase activity, though the enzyme distribution patterns were different from each other as shown in Fig. 5 . Immunostaining of telomerase in M-ESCs demonstrated high activity in the peri-nuclear cytoplasm (Fig. 5A ). Although only a little reactivity was shown in the nucleus of the M-ESCs, telomerase immunoreactivity of MSCs was mainly demonstrated in the nucleus (Fig. 5B) . High telomerase activity in both cell types was indicated by immunostaining and was confirmed by quantitative telomerase activity assay. The same number of undifferentiated M-ESCs, MSCs sorted by MACS, ADSCs isolated from adipose tissues and blood cells, were assayed using a quantitative telomerase detection kit, and activity per 1 Â 10 5 cells was calibrated and analyzed by a standard TSR control value (Fig. 5C,D) . The activity of 1 Â 10 5 MSCs was 0.09370.001 amoles/mL and was lower than 0.2570.008 amoles/mL in M-ESCs. However, both cells showed extremely high activity compared to ADSCs and blood cells, i.e. 0.0004370.00001 amoles/mL and 0.0001670.00001 amoles/mL, respectively. Though MSCs had high telomerase activity, it was lower than that of undifferentiated M-ESCs (Fig. 5D ).
Transplantation to immunodeficient mice; differentiation potential in vivo and teratoma formation
Potential differentiation into mesenchymal cells in vivo was examined by transplantation to SCID mice. MSCs were transplanted into injured tibialis anterior skeletal muscles 24 h after clamping. Transplanted cells located at the injected area were aggregated into a colony and did not move to other regions during the following 1 or 2 weeks. They were clearly distinguished from host cells by their EGFP immunoreactivity (Fig. 6) . After 1 week of transplantation, EGFP-positive cells at the center of the colony assumed a small and round appearance with a nucleus and made contact with each other in the cross-section of the tibialis anterior muscle. At the peripheral region of the colony, EGFP-positive cells grew larger, some of them expressing M-cadherin immunoreactivity. At the outermost region of the colony, they became even larger and showed MHC immunoreactivity. Their nuclei were located at the center of the cells and occasionally appeared as multinuclear cells in the cross-section (Fig. 6A) . After 2 weeks of transplantation, MHC-positive cells increased and became large enough to involve several nuclei in the cross-section. From the HE staining, many blood vessels invaded the colony of transplanted cells. Flk1-positive cells indicating blood vessels frequently overlapped with EGFP immunoreactivity, suggesting that transplanted cells had differentiated into the endothelial cells of blood vessels (Fig. 6B) .
When undifferentiated M-ESCs (1 Â 10 5 cells) were transplanted to subcutaneous inguinal regions, M-ESCs formed clearly identifiable teratoma after 1 month and mice showed a spastic gait (Fig. 7A) . The teratoma tissue showed high EGFP fluorescent, when it was observed under the fluorescent dissection microscope (Fig. 7A insertion) . Tissue section stained with HE indicated rosettes of neural ectoderm, mesodermal cartilage-like structure, endodermal gut epithelium with goblet cells and ciliated respiratory epithelium ( Fig. 7B-E) . On the other hand, the same number of implanted MSCs did not form teratoma 1 month after injection. We could not find any EGFP expressing tissues or cell aggregation at the subcutaneous layer (Fig. 7F) . After 6 months of transplantation, MSCs did not form any clumps of teratoma subcutaneously, and the host mouse survived without any trouble.
Distinct properties from undifferentiated M-ESCs; gene expression profiles by DNA microarray and RT-PCR
MSCs showed an extremely high expression in genes related to the processes of differentiation into mesenchymal cells (Fig. 8A and supplement Table 1 ). The following genes were highly expressed in MSCs: Fndc3b, Pparg, Adrb1and Tgfb1i1 were related to adipogenesis, while Enpp1, Ihh and Csf1 were involved in osteogenesis. Bmp3 and Sox9 were related to chondrogenesis, and MyoD1 and Myogenin were linked to myogenesis. On the other hand, genes required for pluripotency were expressed at very low levels compared to undifferentiated M-ESCs (Fig. 8B) . For example, Sox2, Oct4, Stat3 and Nanog were highly expressed in undifferentiated M-ESCs, but not in MSCs; the data were confirmed by RT-PCR (Fig. 3E) . Besides CD105, cell surface markers of mesenchymal cells that were commonly expressed in MSCs were prominent as previously described. Low-expressing genes were also at a low level in the profiles (see Fig. 8C ). Among immune response-related genes, MHC I genes were positive, while MHC II genes were negative (Fig. 8C ). Other genes with high or low expression are listed in Table 2 .
Discussion
Expression and specificity of CD105
CD105, also known as endoglin, is a homodimeric-type transmembrane glycoprotein that binds to TGF-b1 and TGF-b3 to form gene expression profiles that identify MSCs have involved CD105 (Schffler and Büchler, 2007; Trivedi and Hematti, 2008) . Actually, the Lian group isolated CD105þ cells as MSCs from human ES cells (Lian et al., 2007) . After the completion of adipogenesis, mature adipocytes did not express CD105. Fully differentiated chondrocytes that showed collagen-type II immunoreactivity did not express CD105 (Majumdar et al., 2000) . MSCs or progenitor cells in any type of mesenchymal tissues likely express CD105 as a common marker, whereas mature mesenchymal cells themselves lose the expression. Our protocol for generation of MSCs through partial adipogenesis increased CD105þ cells (Fig. 1B) , so it is one of the efficient ways to obtain MSCs from M-ESCs. CD105, however, is not a specific marker for MSCs. Many reports have indicated that endothelial cells of blood vessels present CD105 as well (Neumüller et al., 2006; Rohde et al., 2006; Perlingeiro, 2007) . In our system, another group of cells with CD105 appeared at day 18 with morphological features quite different from those of our sorting cells. A second group of cells resembled long, slender endothelium. Those endothelium-like cells were readily distinguished from the first group of cells by their shape and the time of their appearance. Therefore, MACS sorting at day 14 during adipogenesis was a very critical time. CD105þ cells obtained by MACS after 8-10 days of induction of adipogenesis were a distinctly homogeneous population in the present study. Therefore, CD105 was established as a useful marker to separate and collect MSCs in our system. The isolation efficiency rate with MACS was more than 91%. This was further enhanced using a technique of adhesion separation after sorting by MACS as described in the Methods section.
Recently, a few groups reported that a part of neuroepithelial cells were the origin of MSCs (Takashima et al., 2007; Billon et al., 2007) . One of them indicated that transiently expressing Sox1 and PDGFr-a cells gave rise to MSCs in vivo and demonstrated it in vitro using a differentiation protocol similar to ours (Billon et al., 2007) . Though they did not describe the expression of CD105 in their MSCs, we presume their MSCs are similar to ours. Actually, our MSCs expressed PDGFr-a (Fig. 1C) .
Potential differentiation into mesenchymal cells, especially skeletal muscle
Our MSCs demonstrated a high potential for differentiation into mesenchymal-type cells, i.e., adipocytes, chondrocytes, osteogenic cells and skeletal muscles in vitro and in vivo. Their differentiation potential indicates that CD105þ cells sorted by MSCS were MSCs, and that was subsequently confirmed as such by their gene-expression profile. Our MSCs were differentiated and sorted during adipogenesis, suggesting that they corresponded to ADSCs. Our MSCs were easily differentiated into skeletal muscles, though both MSCs and ADSCs isolated from tissues in vivo have been described as hardly differentiating into muscles or as requiring forced expression of MyoD for the completion of myogenesis (Majumdar et al., 2000; Kawaguchi, 2006; Lian et al., 2007; Goudenege et al., 2009) . Our data on ADSCs isolated from adipose tissue confirmed the previous reports. In general, the requirement for the provision of specific MSCs does not in fact involve the potential for skeletal muscle differentiation (Schffler and Büchler, 2007) . The prominent potential of our MSCs from M-ESCs to differentiate into skeletal muscle probably depends on the medium containing insulin and T3 for adipogenesis before sorted by MACS. Skeletal muscle cells are sensitive to insulin and the IGF family as growth factors. IGF-II promotes myogenesis through Rho-ROCK activity and induces myoD1 (Rosen and MacDougald, 2006; Wilson and Rotwein, 2006) . We found that myoD1 expression was sustained at quite a high level in our MSCs by DNA array analysis. The receptors of insulin and/or IGFs may be highly expressed before induction of myogenesis in our MSCs. In fact, DNA array analysis showed a high expression of IGF receptor I and II genes in our MSCs (Fig. 8A) . Culture conditions generating our MSCs showed advantages over myogenesis in our method. Recently, MSCs were developed from human ES cells using CD105 as a useful marker of MSCs (Lian et al., 2007) . Their protocol did not involve adipogenic induction by the medium containing insulin and T3. The potential for differentiation into skeletal muscle cells both in vitro and in vivo from the human MSCs was not described at all. Actually, gene expression profiles by DNA array did not show any high IGF score and their receptor family members (Lian et al. 2007 , Supplementary data 2). Therefore, one of the advantages of our protocol and our MSCs is easy derivation of skeletal muscle cells compared to previous methods.
Advantages of MSCs derived from M-ESCs
Besides easy myogenesis, our MSCs have several more suitable features than other MSCs reported. Analysis of the telomerase activity in our MSCs demonstrated high activity but lower than that of undifferentiated M-ESCs (Fig. 5) . Telomerase maintains telomere length that is shortened during cell division and limits the life span of the cell. Many reports have indicated that telomerase expression in ES cells and cancer stem cells is quite high; however, the expression in MSCs and ADSCs from either human or rodents is extremely low. Some MSCs completely lack telomerase activity (Simonse et al., 2002; Zimmermann et al., 2003; Serakinci et al., 2008; Shay and Wright, 2010; Flores and Blasco, 2010) . The low telomerase activity resulted in short life span, cellular senescence and arrested growth (Simonse et al., 2002) . When telomerase was ectopically expressed in MSCs, the mean telomere length was increased and differentiation potential was activated. Further, it extended the proliferative life span. Therefore, high telomerase activity in our MSCs has advantages over other MSCs obtained from adult tissue in vivo.
Our MSCs showed sustained cell growth for long-time culture of more than 10 passages (almost 1-month culture) without abnormal karyotype alteration. During long-time culture MSCs also kept the potential for differentiation into mesenchymal cell lineages (Fig. 4) . Usually, MSCs have never maintained their growth and differentiation potential over such a long time (Javazon et al., 2004; Kern et al., 2006; Peng et al., 2008) . Long stability under the culture condition may arise from high telomerase activity. Indeed, ADSCs isolated from adipose tissue in our experiment showed a low telomerase activity and a short growth period with lower differentiation potential than those of our MSCs. Similar differentiation potential of ADSCs was presented in the report we referred to regarding isolation (Lin et al., 2006) . Thus, long-time culture with a high potential for differentiation is a useful feature of our MSCs. 
Differentiation potential in vivo
After injection into the injured tibialis anterior, MSCs were differentiated into skeletal muscles in vivo. These findings suggest that the fate of MSCs ultimately depends on their micro-environments as already described (Schffler and Büchler, 2007) . Induction factors from host tissues surrounding MSCs regulate their differentiation into a certain mesenchymal cell type. Furthermore, MSCs also differentiated into blood vessels in the regeneration of skeletal muscle tissue in the tibialis anterior. Blood vessels in regenerating tissues were incorporated into both MSCs and host cells. Recently, the transplantation of MSCs has been reported as promoting regeneration after transplantation and showing supporting effects by their angiogenic potential (Banas et al., 2008; Constantin et al., 2009 ). MSCs form vessels by themselves, while also secreting significant amounts of angiogenesis mediators, such as VEGF, HGF, FGF-2, TGF-b and angiopoietin-1 (Oswald et al., 2004; Wang et al., 2006) . Further studies of the molecular mechanisms of angiogenesis by MSCs should result in improved MSC cell therapies.
Although M-ESCs after 1 month of transplantation into the subcutaneous tissue of inguinal regions formed severe teratoma, MSCs did not made any teratoma under the same environment in vivo, and transplanted animals were kept alive without any trouble for more than 6 months. This is also supported by gene expression profile lacking genes of pluripotency. Avoidance of teratoma formation is the most important, useful and advantageous issue for regeneration therapy. 
Gene analysis indicates specific feature of MSCs derived from M-ESCs
MSCs were compared to undifferentiated M-ESCs. Our MSCs showed typical MSC and ADSC gene expression profiles. The high potential of our MSCs for differentiation into mesenchymal cells was confirmed by the adequate levels of gene expression profiles in adipogenic, osteogenic, chondrogenic and myogenic genes. It is important to note that MSCs expressed not only one cell type but also others among the mesenchymal cells. Under appropriate conditions the balance is tipped, leading to a cascade that promotes the fate of one cell while repressing those of others. In the present study, MSCs maintained the balance between genes related to several cell types. Cell surface makers including MHC classes I and II were also similar to MSCs reported previously (Blanc et al., 2003; Puymirat et al., 2009 ). This suggests a modulation of immune cell responses that could be therapeutically useful. Further investigation is warranted.
In contrast, the expression of genes maintaining undifferentiation such as Sox2, oct4, stat3 and Nanog was at very low levels, and this finding was corroborated by RT-PCR. Most data from DNA arrays were similar to other MSCs or ADSCs reported (Olivier et al., 2006; Lian et al., 2007) . MSCs lost pluripotency and obtained high potential for differentiation into mesenchymal cells. This characteristic feature, therefore, can also be beneficial to transplantation in avoiding teratoma formation.
In summary, we developed MSCs with a high potential for differentiation into mesenchymal cell lineages, including skeletal muscles in vitro from M-ESCs using CD105 as a cell surface marker. Depending on their surrounding micro-environments in vivo, MSCs differentiated into skeletal muscles of injured tibialis anterior muscles. They also enhanced vasculogenesis by differentiation into endothelial cells or by the induction of blood vessels from surrounding tissues. Their gene expression profiles indicated low pluripotency, thus avoiding teratoma formation, and all their properties proved very beneficial to cell-derived regeneration and therapeutic usage.
